Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

NCT02371889 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02371889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
December 18, 2014
Completion date
February 29, 2020
Enrollment
320 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), alcoholism